CIISB offers priority and free-of-charge access for COVID-19 research proposals
CIISB is committed to the use its resources in response to the emergency situation of the COVID-19 virus pandemic. CIISB ensures that available technologies support primarily researchers in their efforts to study the virus and projects aiming to the development of an effective vaccine or treatment.
In this context, we are offering priority access to groups that need to use CIISB structural biology services for projects directly related to COVID-19 virus particles. Priority access will ensure a faster review of research proposals relating to COVID-19. To request priority access to CIISB services for COVID-19 related research, please submit a research proposal with COVID-19 in the title of the proposal.
Successfully accepted proposals will be free of charge, and no financial contribution will be requested for the measurement/service.
More articles
-
Webinar series: What can iNEXT-Discovery do for us? Jan Wollenhaupt, HZB, How to do crystallographic fragment screening at the Helmholtz-Zentrum Berlin
The webinar series What can iNEXT-Discovery do for us? will continue on November 2 at 16:00 CEST with the topic "How to do crystallographic fragment screening at the Helmholtz-Zentrum Berlin" presented by Jan Wollenhaupt, HZB.
-
Emerging Topics in Biomolecular Magnetic Resonance - Marina Bennati (Max Planck Institute for Biophysical Chemistry) and Nathaniel Traaseth (New York University)
The series Emerging topics in Biomolecular Magnetic Resonance will continue on October 29th at 16:00 CEST with the following lecturers and topics:
- Marina Bennati (Max Planck Institute for Biophysical Chemistry):Structure and function of biomolecules by detecting nuclear spins with EPR